Although cyclin E gene amplification is reported to be an important event i
n various cancers, it is rarely found in human colorectal cancers. As one o
f the candidate factors of other mechanisms relating to cyclin E, we analyz
ed cyclin E-dependent kinase activity in colorectal cancer. Protein levels
of cyclin E, its catalytic subunit, cyclin-dependent kinase 2 (Cdk2), and p
21 and p27 were determined by western blot or immunohistochemistry in 27 co
lorectal cancers and 10 colorectal adenomas, and compared with adjacent nor
mal colonic mucosa. Enzymatic activity of cyclin E-Cdk2 complex in the colo
rectal neoplasm was measured using in-gel kinase assay using glutathione S-
transferase-retinoblastoma (GST-Rb) fusion protein as substrate, and compar
ed with that of normal mucosa. We clearly showed that although the protein
level of cyclin E in colorectal cancer and adenoma was similar to that of a
djacent normal mucosa, cylin E-dependent kinase activity was increased in a
ll the cases of colorectal cancers and 90% of colorectal adenomas. The rela
tive kinase activity was significantly higher in colorectal cancer (3.7 +/-
1.7 -fold) than colorectal adenomas (2.0 +/- 0.8-fold) (P < 0.004). The re
lative expression level of Cdk2 protein in cancer was significantly higher
than adenoma (4.4 +/- 2.4 vs 2.7 +/- 1.3, P < 0.04), and p21 and p27 were n
ot detected in colorectal cancer and notably decreased in adenoma. The resu
lts of this study strongly suggest that activation of cyclin E-dependent ki
nase activity may play an important role in colorectal cancer, and its leve
l appears to be related to increased Cdk2 and decreased p21 and p27 amounts
rather than cyclin E protein level.